Ticketplus Ltd. announced the pricing of its initial public offering of 1,875,000 ordinary shares at $8.00 per share, raising $15 million in gross proceeds. The company's ordinary shares are expected to begin trading on NYSE American on August 7, 2026, under the symbol "TP". Underwriters were granted a 45-day option to purchase up to 281,250 additional shares.

Team, Inc. announced it will release its second quarter 2026 earnings on Monday, August 10, 2026, after the close of trading. The company will host a conference call to discuss its financial and operational results on Tuesday, August 11, 2026, at 8:00 a.m. Central Time. Interested parties can access the live webcast via the company's investor relations website or by dialing into the conference call.

Tango Therapeutics, Inc. announced that Dr. Barbara Weber, the Executive Chairman of its Board of Directors, will be stepping down from her position. Dr. Weber is leaving to pursue other interests, expressing confidence in the company's accomplishments and future prospects. Tango Therapeutics acknowledged her significant contributions, including her vision, leadership, and dedication to the company's groundbreaking work.

Biogen Inc. announced the completion of its acquisition of RayThera Inc., a privately held biotechnology company specializing in small-molecule therapies for immunology. This acquisition is expected to strengthen Biogen's growing immunology portfolio by adding multiple assets, with the lead program having entered Phase 1 development in July 2026. Biogen views this as a strategic move to diversify its pipeline and drive long-term growth.

Pacific Airport Group announced that Alejandra Soto will step down from her position as Investor Relations and Social Responsibility Officer, effective August 7, 2026. Soto has been with the company for over 18 years. Saúl Villarreal, the current Chief Financial Officer, will assume responsibility for the Investor Relations function.

B2Gold Corp. reported Q2 2026 consolidated gold production of 203,648 ounces, with adjusted net income of $0.03 per share and a free cash outflow of $258 million. The company narrowed its 2026 consolidated gold production guidance to 820,000-920,000 ounces and lowered its all-in sustaining costs guidance to $2,370-$2,550 per gold ounce sold. Strategic actions included the sale of a 70% interest in Fingold for $325 million and the repurchase of $92 million in shares. The Menankoto Exploitation Permit is awaiting final approval, and repairs at the Goose Mine crushing circuit are on track for Q3 completion.

Ernexa Therapeutics Inc. reported a net loss of $4.0 million for the three months ended June 30, 2026, and $9.5 million for the six months, which included a $2.0 million goodwill impairment charge. The company ended the period with $5.0 million in cash and an accumulated deficit of $255.2 million. Management noted a going concern risk but expects to cover shortfalls through its At-the-Market (ATM) program, having raised $3.7 million post-quarter end.

Iovance Biotherapeutics updated its corporate presentation, highlighting strong financial performance and significant pipeline progress. The company reported 2Q26 revenue of approximately $99 million, exceeding its guidance by over 10%, and achieved a 56% gross margin from cost of sales. With a cash position of $304 million, Iovance projects a cash runway into the second half of 2028. The presentation also detailed advancements in its TIL therapy pipeline, including positive clinical data for lifileucel in NSCLC and soft tissue sarcomas, and ongoing global expansion with over 95 treatment centers.

Tango Therapeutics announced that Dr. Barbara Weber's employment as Executive Chair ended on August 3, 2026, leading to her resignation from all officer and board positions. Her departure was not due to any disagreement with the company. In connection with her separation, Dr. Weber was offered a severance package including base salary through December 31, 2026, COBRA reimbursement, accelerated vesting of stock awards, and a pro-rata annual incentive.

Savers Value Village, Inc. reported strong financial results for the second quarter and first half of 2026. Net sales for the thirteen weeks ended July 4, 2026, increased 7.4% to $448.2 million, with net income rising 14.3% to $21.6 million. The company also amended its 2025 Senior Secured Credit Facilities to reduce interest rates and continued its share repurchase program, buying back 1.18 million shares for $9.5 million in the quarter.

Granite Ridge Resources reported a net income of $29.996 million for the second quarter of 2026, an increase from $25.081 million in the same period last year, with oil and natural gas sales rising to $149.273 million. However, the company recorded a net loss of $17.035 million for the first six months of 2026, primarily due to significant impairments of unproved oil and gas properties totaling $20.323 million and derivative losses. The company also completed its reincorporation from Delaware to Texas in August 2026.

Caring Brands, Inc. announced an update to its intellectual property portfolio, which now includes five issued U.S. patents covering its Hair Enzyme Booster and Photocil product platforms. Four patents protect the Hair Enzyme Booster, targeting a $1.8 billion+ hair care market, while one patent covers Photocil, aimed at a $20 billion+ dermatology market. The company is focusing on translating this strong legal foundation into scalable commercial opportunities through B2B licensing and direct-to-consumer sales, despite an ongoing Nasdaq delisting appeal.

Bunker Hill Mining Corp. announced its first concentrate shipment to Teck's Trail Smelter, marking the start of revenue generation from its mine after 45 years. The company is commissioning its new 1,800 tpd processing plant, targeting full commercial production by year-end 2026. To support ongoing operations and working capital, Bunker Hill also drew US$5.0 million from its existing US$10.0 million standby facility with Teck Metals Ltd. Additionally, the company adopted amended bylaws to update procedures for stockholder proposals and director nominations.

INCOME OPPORTUNITY REALTY INVESTORS INC reported a net income of $705K and EPS of $0.17 for the three months ended June 30, 2026, a decrease from $994K and $0.24 in the prior year. For the six months, net income was $1.715M and EPS $0.42, also a decrease primarily due to lower interest income from related parties. The company's total assets increased to $127.64M. A subsequent event noted Transcontinental Realty Investors, Inc. (TCI) acquired 269,299 common shares from Realty Advisors, Inc. on July 31, 2026.

Intermap Technologies announced it will release its second quarter 2026 financial results after market close on August 13, 2026. Following the release, Chairman and CEO Patrick A. Blott and CFO Jennifer Bakken will host a live webcast and investor Q&A session at 5:00 pm ET to discuss the results.